Koji Yoshinaga

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

Daisuke Kawasaki, Yutaka Emori, Runa Eta et al. · Cancer Chemotherapy and Pharmacology · 2007 · 37 citations

Tumor Biology, Action Determinations, Oncology +9

Effect of polaprezinc on taste disorders in zinc‐deficient rats

Hiroki Hamano, Koji Yoshinaga, Runa Eta et al. · BioFactors · 2006 · 36 citations

Synthesis of Prolyl Endopeptidase Inhibitors and Evaluation of Their Structure-Activity Relationships: In Vitro Inhibition of Prolyl Endopeptidase from Canine Brain.

S Niwa, Koji Yoshinaga, Naoyoshi Miura · Chemical and Pharmaceutical Bulletin · 1993 · 33 citations · Full text

Pharmaceutical Science, Chemical Modification, Pharmacotherapy +16

Antimetastatic Effect of an Immunomodulatory Arabinomannan Extracted from Mycobacterium tuberculosis Strain Aoyama B, Z-100, through the Production of Interleukin-12

Hideki Oka, Yumiko Shiraishi, Hidetaka Sasaki et al. · Biological and Pharmaceutical Bulletin · 2003 · 28 citations · Full text

Immunology, Immunoediting, Immunologic Mechanism +24

Z-360, a Novel Therapeutic Agent for Pancreatic Cancer, Prevents Up-Regulation of Ephrin B1 Gene Expression and Phosphorylation of NR2B via Suppression of Interleukin-1β Production in a Cancer-Induced Pain Model in Mice

Yuki Orikawa, Hiroki Kato, Koichi Seto et al. · Molecular Pain · 2010 · 27 citations · Full text